Arthur Schmidt1, Tilman Pickartz2, Markus M Lerch2, Fabrizio Fanelli3, Fausto Fiocca4, Pierleone Lucatelli3, Fabrizio Cereatti4, Albrecht Hoffmeister5, Werner van Steenbergen6, Matthias Kraft2,7, Benjamin Meier1, Karel Caca1. 1. Department of Gastroenterology, Klinikum Ludwigsburg, University of Heidelberg, Germany. 2. Department of Medicine A, University Medicine Greifswald, Germany. 3. Department of Interventional Radiology, Sapienza University of Rome, Italy. 4. Department of Surgery, Sapienza University of Rome, Italy. 5. Department of Interdisciplinary Endoscopy and Sonography, Clinic of Gastroenterology, University of Leipzig, Germany. 6. Department of Hepatology, University of Leuven, Belgium. 7. Current address: Department of Gastroenterology, Vinzentius Krankenhaus, Landau, Germany.
Abstract
BACKGROUND: Temporary placement of removable, fully covered, self-expandable metal stents (fcSEMS) for treatment of benign biliary strictures (BBS) has been reported to be effective. However, the optimal extraction time point remains unclear and stent migration has been a major concern. OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of this treatment modality using an fcSEMS with a special antimigration design and prolonged stent indwell time. METHODS: We performed a prospective, single-arm study at six tertiary care centers in Europe. Patients with BBS underwent endoscopic or percutaneous implantation of an fcSEMS (GORE® VIABIL® Biliary Endoprosthesis, W.L. Gore & Associates, Flagstaff, AZ, USA). The devices were scheduled to be removed nine months later, and patients were to return for follow-up for an additional 15 months. RESULTS: Forty-three patients were enrolled in the study. Stricture etiology was chronic pancreatitis in the majority of patients (57.5%). All fcSEMS were placed successfully, either endoscopically (76.7%) or percutaneously (23.3%). Stent migration was observed in two patients (5.2%). Primary patency of the SEMS prior to removal was 73.0%. All attempted stent removals were successful. At removal, stricture was resolved or significantly improved without need for further therapy in 78.9% of patients. Stricture recurrence during a follow-up of two years post-implant was observed in two patients. CONCLUSIONS: Temporary placement of the fcSEMS is a feasible, safe and effective treatment for BBS. The design of the device used in this study accounts for very low migration rates and facilitates easy stent retrieval, even after it has been in place for up to 11 months.
BACKGROUND: Temporary placement of removable, fully covered, self-expandable metal stents (fcSEMS) for treatment of benign biliary strictures (BBS) has been reported to be effective. However, the optimal extraction time point remains unclear and stent migration has been a major concern. OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of this treatment modality using an fcSEMS with a special antimigration design and prolonged stent indwell time. METHODS: We performed a prospective, single-arm study at six tertiary care centers in Europe. Patients with BBS underwent endoscopic or percutaneous implantation of an fcSEMS (GORE® VIABIL® Biliary Endoprosthesis, W.L. Gore & Associates, Flagstaff, AZ, USA). The devices were scheduled to be removed nine months later, and patients were to return for follow-up for an additional 15 months. RESULTS: Forty-three patients were enrolled in the study. Stricture etiology was chronic pancreatitis in the majority of patients (57.5%). All fcSEMS were placed successfully, either endoscopically (76.7%) or percutaneously (23.3%). Stent migration was observed in two patients (5.2%). Primary patency of the SEMS prior to removal was 73.0%. All attempted stent removals were successful. At removal, stricture was resolved or significantly improved without need for further therapy in 78.9% of patients. Stricture recurrence during a follow-up of two years post-implant was observed in two patients. CONCLUSIONS: Temporary placement of the fcSEMS is a feasible, safe and effective treatment for BBS. The design of the device used in this study accounts for very low migration rates and facilitates easy stent retrieval, even after it has been in place for up to 11 months.
Authors: Jong Kyu Park; Jong Ho Moon; Hyun Jong Choi; Seul Ki Min; Tae Hoon Lee; Gab Jin Cheon; Young Koog Cheon; Young Deok Cho; Sang-Heum Park; Sun-Joo Kim Journal: Am J Gastroenterol Date: 2011-07-26 Impact factor: 10.864
Authors: Jacques Devière; D Nageshwar Reddy; Andreas Püspök; Thierry Ponchon; Marco J Bruno; Michael J Bourke; Horst Neuhaus; André Roy; Ferrán González-Huix Lladó; Alan N Barkun; Paul P Kortan; Claudio Navarrete; Joyce Peetermans; Daniel Blero; Sundeep Lakhtakia; Werner Dolak; Vincent Lepilliez; Jan W Poley; Andrea Tringali; Guido Costamagna Journal: Gastroenterology Date: 2014-05-04 Impact factor: 22.682
Authors: Carola Haapamäki; Leena Kylänpää; Marianne Udd; Outi Lindström; Juha Grönroos; Arto Saarela; Harri Mustonen; Jorma Halttunen Journal: Endoscopy Date: 2015-01-15 Impact factor: 10.093
Authors: B Mangiavillano; G Manes; T H Baron; R Frego; M Dinelli; F Radaelli; V Teruzzi; A Amato; S Pallotta; T Santoro; E Masci Journal: Dig Dis Sci Date: 2014-04-20 Impact factor: 3.199